Amgen Inc.

NasdaqGS:AMGN

Sector

🏥 Health Care

Industries

🧬 Biotechnology

🔬 Clinical Trials

💊 Pharmaceuticals

🔍 Research & Consulting

💉 Vaccines

Location

United States

Market Cap

USD 161.35 B

Share Price

USD 284.67

Avg Daily Volume

2,557,616

Change (1 day)

-5.13%

Change (1 year)

-13.46%

Change (YTD)

9.22%

Amgen Inc. Operating Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2025: USD 12.19 B

Amgen Inc. Operating Cash Flow is USD 12.19 B for the Trailing 12 Months (TTM) ending March 31, 2025, a 50.59% change year over year. Operating cash flow is cash generated from the company’s regular business operations.

Amgen Inc. Operating Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2024 was USD 8.10 B, a -6.09% change year over year.
Amgen Inc. Operating Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2023 was USD 8.62 B, a -7.51% change year over year.
Amgen Inc. Operating Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2022 was USD 9.32 B, a -10.95% change year over year.
Amgen Inc. Operating Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2021 was USD 10.47 B, a 10.89% change year over year.